Aside from IFNγ, cohort 4 patients also had elevated levels of IL-6, IL-8 and MCP-1 coupled with little modulation of IL-1β that reflects observations made in B-ALL patients receiving CD19 CAR T cells [5]. Here, CXCL8 is linked to precursor B-cell acute lymphoblastic leukemia.